%D9%88%D8%B1%D9%85_%D9%84%D9%8A%D9%81%D9%8A_%D8%B9%D8%B5%D8%A8%D9%8ACategory:NeurofibromaNeurofibromNeurofibromNeurofibromaNeurofibrome%D7%A0%D7%95%D7%99%D7%A8%D7%95%D7%A4%D7%99%D7%91%D7%A8%D7%95%D7%9E%D7%94NeurofibromaNeurofibromaNerwiakow%C5%82%C3%B3kniak%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%BC%D0%B0Q1418735
about
Neurofibromatosis Type 1 Brain Tumor Genetic RiskPLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)AZD6244 Hydrogen Sulfate for Children With Nervous System TumorsSorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform NeurofibromasNatural History Study of Patients With Neurofibromatosis Type 2Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug DevelopmentReliability of Functional Outcome Measures in Neurofibromatosis 2A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasVitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)Quality of Friendships in Children With NeurofibromatosisTopical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1Concentration and Activity of Lapatinib in Vestibular SchwannomasA Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male ParticipantsTreatment of NF1-related Plexiform Neurofibroma With TrametinibStudy of Imatinib in Children With Neurofibromatosis and Airway TumorsStudy of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) ChildrenDexmedetomidine and Propofol for Pediatric MRI SedationPhase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasBevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseEfficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) PatientsAnalysis of Data Collected From Individuals Administered Neurobehavioral AssessmentsPhase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade AstrocytomasStereotactic Body Radiotherapy for Spine TumorsStudy of RAD001 for Treatment of NF2-related Vestibular SchwannomaSARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath TumorsResiliency Training for Adults With Neurofibromatosis Via Live VideoconferencingIntermittent Dosing Of Selumetinib In Childhood NF1 Associated TumoursNon-invasive Stimulation in Neurofibromatosis Type 1Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway GliomaPomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsAdaptation and Quality of Life Among Adults With Neurofibromatosis Type ITransformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15Whole-body Vibration in Children With Neurofibromatosis Type 1Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II PatientsStudy of Plexiform Neurofibromas in Neurofibromatosis Type 1
P1050
Hybrid peripheral nerve sheath tumors: report of five cases and detailed review of literature.Neurofibroma of the bile duct: a rare cause of obstructive jaundiceTHE HISTOLOGICAL CLASSIFICATION OF LOWER RESPIRATORY TRACT TUMOURSPreclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare caseHuman stem cell modeling in neurofibromatosis type 1 (NF1).Neurofibroma involving obturator nerve mimicking an adnexal mass: a rare case report and PRISMA-driven systematic review.[Neurinoma as a rare indication for termination of pregnancy with cesarean section]Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)Natural History Study of Patients With Neurofibromatosis Type IExpanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlationNail bed solitary neurofibroma: A case report and literature reviewPainful Vater-Pacini neuroma of the digit in neurofibromatosis type 1
P921
Q61707462-EDD6761B-AF77-44E7-AE72-21142CB2BD7FQ61864692-B1E41374-9FA4-4412-81AF-4CE2B0FB76ABQ61864912-DD7F661E-D2B2-4BBB-885F-F5F1A8909EE3Q61865088-EF9B0652-6776-4D1D-88B2-705D8C72CAB7Q61865106-5BCFDDAE-0E4E-4CA7-8392-3866AE1ECBE4Q61865218-CDA752EF-98CB-4839-A868-2ADBC91CE7F6Q61904770-7CA9056C-106C-41E6-AA01-09C42605C6F2Q61915528-6000774B-54AD-4A01-9AA6-60121FE23BF7Q61975501-DD03F705-4EB6-47F2-9006-1CF0F040C99CQ61979641-A8ABDC3B-3623-419F-865B-22CA058426A1Q61981053-97AD6E82-A4A1-44B7-B23E-DA3F050DDD98Q61981268-B49ACE17-9C7B-43C0-BC44-995EE305F09BQ62025528-2182EB34-038F-4A67-B17B-6A57CA38CE75Q62034875-5B40ABBB-1788-4487-A5CA-E11F80CD81C4Q62054321-D88C361A-8741-4E08-93B0-79C224DBB4AFQ62105154-DBB4E4EB-EE1A-4169-9526-86B177DFAB5BQ62817101-461504D3-49A1-4EEF-BDA5-7A25EE6A485EQ62819046-1953ADF9-716D-4FF0-9394-862152BA052BQ63012420-EADFFD15-C50E-46E0-8804-34C327A2E427Q63319547-798A3166-0D0F-4CEF-93D3-30BA89E220AFQ63320831-E8829B76-4682-4A2F-97B4-8862FCF6A72AQ63321687-C7139903-3F06-49D2-A3E6-5C672736575DQ63322414-9354581B-BCE3-4F8B-8E31-359F9B941451Q63333835-ADFEB1E4-7511-4D42-B33A-E31DDC23ACDAQ63335274-A4305EB5-5FFC-4FF7-BE90-AB243D18136CQ63335811-B7BFF2BD-C925-42F3-8241-28DDD9A5E634Q63336466-2980D1C4-573D-4B9A-AF7B-DDA6ECC81592Q63403454-AB9BF46E-F552-4CB5-AD00-5AF239FBB53CQ63404478-BB7B93E1-45EE-414D-8A05-F02DBA323A35Q63534280-CF26CE9C-86E2-4902-AB70-BD01C29B69F8Q63572555-E72BDC16-6D8A-4494-8B25-E6E6D5A35596Q63572691-5C435E69-13E8-4321-876E-597381BBCC0CQ63576396-57DE467F-F645-49AA-8684-456DC9FFB386Q63576933-5CCF4DF3-FDBD-4DC6-BBDB-785CFA7D364CQ63577025-FF5BB8F7-E167-481C-B665-30C9D5AFCB95Q63577437-F219729B-25EC-41F3-A096-9FCA05B2EA26Q63579807-B9AF406C-2511-4321-A2FE-28992B44B1BFQ63581192-BA9AD1D2-6213-42B4-B646-D15850C6A5C5Q63591143-5637B768-E365-4812-94C9-D4519DFA9E5DQ63591380-83C46EFF-361D-42AF-A6D8-6B2CC5EA7BED
P1050
Q18554231-1426AC76-47F7-4B65-BE5C-5C07DB13AA41Q18554591-8DCF387D-41C4-479B-988C-BDF6FC5ED1D5Q18555153-83B5BE53-A2C9-4016-88D2-95AB2D108870Q18555964-8BB6FE52-2C5F-4E2C-A122-566F8A70F4DDQ18556647-7B48D071-26C5-4DBF-A4D5-B4F6A6B2CCB9Q18556648-788BD865-6F62-4DCA-8494-89509818EC30Q18556649-52C4BC9F-1F6D-4EFB-917B-0FCA597A0ADBQ18556650-E5AD0A6A-CE9E-4E19-BC79-E86EBA641168Q18556651-448CD9BE-FB14-43E9-A0B9-D3C56D9122E5Q18558099-9648D113-D11F-4D9A-82B8-546C88E5AEE5Q18558179-5A69937C-1778-4EB0-9770-B79E285AB325
P279
Q33709081-E39B2F3B-CFA6-4BC5-BDFB-0D5B2BD658AAQ33902382-4763576B-F2B9-4F36-976A-AE8D398B01B8Q35392821-7E54C4BD-F194-4D51-BA70-0FD3508D6362Q35987649-E1A7B6AA-EC38-41B8-8763-5ED44F1135CDQ37632605-450869B0-6008-443C-AFC2-5E9BB6B24A24Q38732807-3ACEC042-BF82-43E5-99F3-5832C4D42EDAQ49731052-0A03E3FC-59C6-4186-844D-F75E65317C97Q61846334-6EAD937A-91F0-40A7-9AB8-FD5AAF5B1EBAQ62105154-AB5149EA-80AB-42ED-9BFB-AF4B4807138FQ63804859-83202656-AD78-4530-8E22-1A98AD569109Q64043292-7D08D7B6-42F3-4AD1-B4C6-D1BAE2E04545Q64235254-466377A7-B3E9-4FDB-9DFF-14508F3BBF39Q64286730-6E7FA478-1A3B-45C6-BC2A-CF120B78F21E
P921
description
Doença humana
@pt
Human disease
@en
Krankheit
@de
Tumore anizkoitza, nerbio peri ...... tan oinarrizko ezaugarria dena
@eu
nádorové onemocnění
@cs
مرض يصيب الإنسان
@ar
name
Nerwiakowłókniak
@pl
Neurofibrom
@cs
Neurofibrom
@de
Neurofibroma
@it
Neurofibroma
@lt
neurofibroma
@en
neurofibroma
@eu
neurofibromatoses
@pt
neurofibrome
@fr
Нейрофиброма
@ru
type
label
Nerwiakowłókniak
@pl
Neurofibrom
@cs
Neurofibrom
@de
Neurofibroma
@it
Neurofibroma
@lt
neurofibroma
@en
neurofibroma
@eu
neurofibromatoses
@pt
neurofibrome
@fr
Нейрофиброма
@ru
prefLabel
Nerwiakowłókniak
@pl
Neurofibrom
@cs
Neurofibrom
@de
Neurofibroma
@it
Neurofibroma
@lt
neurofibroma
@en
neurofibroma
@eu
neurofibromatoses
@pt
neurofibrome
@fr
Нейрофиброма
@ru
P672
P486
P6366
P646
P1296
P1748
P1995
P2892
P31
P373
Neurofibroma
P3827
neurofibroma
P4746
P486
P563
P6366
2777831590
P646
P672
C04.557.580.600.580
C10.551.775.500.750
C10.668.829.725.500.600